logo

For the Inventor, By the Inventor

Chesterfield, MO, United States of America

Gabrielle R Neises

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents. Top assignee: Monsanto Company. Active years: 1995-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabrielle R Neises. Retrieved from https://idiyas.com/inventor/gabrielle-r-neises

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 287(Granted Patents)


Location History:

  • Chesterfield, GB (1996)
  • Chesterfield, MO (US) (1995 - 2001)

Company Filing History:

goldMedal10 out of 3,289 
 
Monsanto Company
 patents

Years Active: 1995-2001

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 6291657 - Deoxygalactonojirimycin derivatives (2001-09-18),
2. 5801185 - Method of treating Tay-Sachs disease (1998-09-01),
3. 5798366 - Method for treatment of CNS-involved lysosomal storage diseases (1998-08-25),
4. 5786369 - Method of inhibiting the surface expression of glycolipid receptors for (1998-07-28),
5. 5786368 - Deoxygalactonojirimycin derivatives (1998-07-28),
6. 5656641 - Method of inhibiting glycolipid synthesis (1997-08-12),
7. 5580884 - Deoxygalactonojirimycin derivatives (1996-12-03),
8. 5525616 - Method of inhibiting glycolipid synthesis (1996-06-11),
9. 5472969 - Method of inhibiting glycolipid synthesis (1995-12-05),
10. 5399567 - Method of treating cholera (1995-03-21),

Title: Gabrielle R Neises: Innovator in Glycolipid Synthesis and Tay-Sachs Treatment

Introduction

Gabrielle R Neises is a prominent inventor based in Chesterfield, MO (US). She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for medical applications. With a total of 10 patents, her work has had a substantial impact on the treatment of genetic disorders.

Latest Patents

Among her latest patents, Neises has developed deoxygalactonojirimycin derivatives. These novel N-alkyl derivatives contain alkyl groups with 3-6 carbon atoms and are useful for selectively inhibiting glycolipid synthesis. Additionally, she has disclosed a method for treating Tay-Sachs disease, which involves subjecting cells to a glycolipid inhibitory effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol, where the alkyl contains 2-8 carbon atoms.

Career Highlights

Throughout her career, Neises has worked with notable companies such as Monsanto Company and G.D. Searle & Company. Her experience in these organizations has allowed her to refine her expertise in biochemistry and patent development.

Collaborations

Some of her notable coworkers include Frances M Platt and Raymond A Dwek. Their collaborative efforts have contributed to advancements in the field and have furthered the impact of Neises's inventions.

Conclusion

Gabrielle R Neises is a trailblazer in the field of biochemistry, with a focus on innovative treatments for genetic disorders. Her contributions through her patents and collaborations continue to influence the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…